Skip to content

Clinical trials

Phase 2/3 Sarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Phase: Phase 2/3 Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20112
20141
20152
20161
20171
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Unknown status3
Terminated2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris1
Blokhin's Russian Cancer Research Center1
Cancer Research UK1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
European Organisation for Research and Treatment of Cancer - EORTC1
M.D. Anderson Cancer Center1
Nanobiotix1
National Cancer Institute (NCI)1
Peking University People's Hospital1
Pierian Biosciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma10
Breast Neoplasms2
Fibrosarcoma2
Histiocytoma, Malignant Fibrous2
Leiomyosarcoma2
Lung Neoplasms2
Neoplasms2
Neurofibrosarcoma2
Osteosarcoma2
Sarcoma, Alveolar Soft Part2

Trials

Showing 26 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.